Prognostic significance of C-reactive protein-albumin-lymphocyte (CALLY) index after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction-Reference-Cited by-同舟云学术

Prognostic significance of C-reactive protein-albumin-lymphocyte (CALLY) index after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction

Published:2024-11 Issue: Volume:141 Page:112860
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Ji Hao,Luo Zan,Ye Lu,He Ying,Hao Mengyao,Yang Yang,Tao Xingyu,Tong Guoxin,Zhou Liang

Publisher

Elsevier BV

Reference51 articles.

1. Performance of management strategies with class i recommendations among patients hospitalized with st-segment elevation myocardial infarction in China;Hao;JAMA Cardiol.,2022

2. The global burden of ischemic heart disease in 1990 and 2010: the global burden of disease 2010 study;Moran;Circulation,2014

3. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI;McManus;Am. J. Med.,2011

4. Conceptual framework for addressing residual atherosclerotic cardiovascular disease risk in the era of precision medicine;Patel;Circulation,2018

5. B. Ibanez, S. James, S. Agewall, M.J. Antunes, C. Bucciarelli-Ducci, H. Bueno, A.L.P. Caforio, F. Crea, J.A. Goudevenos, S. Halvorsen, G. Hindricks, A. Kastrati, M.J. Lenzen, E. Prescott, M. Roffi, M. Valgimigli, C. Varenhorst, P. Vranckx, P. Widimsky, E.S.C.S.D. Group, 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC), Eur Heart J 39(2) (2018) 119-177.